IAS – the International AIDS Society – and its partners are organizing a one-day pre-meeting, titled “Putting people first in the prevention, treatment and care of HPV-related cancers for people living with HIV”, in conjunction with IAS 2023, the 12th IAS Conference on HIV Science.
View the session recordings here.
The event is at capacity and registration is closed. Add your name to the waiting list by emailing pcc@iasociety.org. Waitlisted delegates are encouraged to be at the venue by 08:30 AEST on 22 July 2023. We will make a decision on whether there is sufficient space for them to enter the venue by 08:50 AEST.
The event will be held at the Pullman & Mercure King George Square Hotel, Corner of Ann & Roma Street, Brisbane, 4000, Australia, on 22 July 2023. The content will be accessible online after the pre-meeting.
This pre-meeting will be of interest to HIV basic scientists, clinicians, researchers, public health practitioners, implementers, community advocates and those working towards preventing and managing HPV-related cancers.
Objective
The objective of the meeting is to bring together a diverse group of scientific, technical and community representatives to discuss current opportunities and challenges for increased prevention and screening for HPV, as well as diagnosis and treatment of intraepithelial neoplasia to prevent cervical cancer and anal cancer in people living with HIV and other populations.
Programme committee
- Adeeba Kamarulzaman, Monash University, Malaysia
- Andrew Grulich, Kirby Institute, University of NSW, Australia
- Azadeh Baghaki, Unitaid, Switzerland
- Joel Palefsky, University of California San Francisco, United States
- Sinead Delany-Moretlwe, University of the Witwatersrand, South Africa
Featured speakers
Programme
| 08:00 – 09:00 | Registration open (coffee and tea provided) | |
| 09:00 – 10:00 | Session 1 – The scale of the challenges Chair: Adeeba Kamarulzaman, Monash University, Malaysia |
|
| 09:00 – 09:05 | Acknowledgement of country and welcome | Andrew Grulich, Kirby Institute, UNSW, Australia |
| 09:05 – 09:10 | Introduction | Adeeba Kamarulzaman, Monash University, Malaysia |
| 09:10 – 09:25 | Pre-recorded My journey of survival and my mission to advocate for integrated services |
Salome Agallo, NCD Alliance, Kenya |
| 09:25 – 09:45 | Keynote HPV-related cancers: Burden, WHO recommendations, progress and opportunities for integration |
Meg Doherty, WHO, Switzerland |
| 09:45 – 09:50 | Pre-recorded Unitaid’s contribution to accelerating elimination of cervical cancer in low-resource settings |
Azadeh Baghaki, Unitaid, Switzerland |
| 09:50 – 10:00 | Making the investment case to catalyze HPV-related cancer prevention and treatment | Karen Canfell, The Daffodil Centre, Cancer Council NSW and the University of Sydney, Australia |
| 10:00 – 10:30 | Break (coffee, tea and morning snack provided) | |
| 10:30 – 12:00 | Session 2 – State of the art guidance for HPV vaccination, screen and treat Chair: Andrew Grulich, Kirby Institute UNSW, Australia |
|
| 10:30 – 10:50 | HPV vaccination | Sinead Delany-Moretlwe, Wits RHI, South Africa |
| 10:50 – 11:10 | Pre-recorded Cervical cancer screen, triage and treatment |
Maribel Almonte, WHO, Switzerland |
| 11:10 – 11:30 | Anal cancer screen and treatment | Joel Palefsky, University of California San Francisco, United States |
| 11:30 – 12:00 | General discussion of session 1 and 2 | Moderated by Andrew Grulich, Kirby Institute UNSW, Australia |
| 12:00 – 13:00 | Lunch (hot and cold lunch options provided) | |
| 13:00 – 14:30 | Session 3 – Good-practice models for HPV-related cancer elimination Chair: Sinead Delany-Moretlwe, Wits RHI, South Africa |
|
| 13:00 – 13:10 | Pre-recorded Latest evidence from the KEN-SHE study |
Nelly Mugo, Kenya Medical Research Institute, Kenya |
| 13:10 – 13:20 | Scaling up access to cervical screening in Malaysia: the ROSE Foundation approach | Marion Saville, Australian Centre for the Prevention of Cervical Cancer, Australia |
| 13:20 – 13:30 | Eliminating cervical cancer in the western Pacific | Andrew Vallely, Kirby Institute UNSW, Australia |
| 13:30 – 13:40 | SUCCESS – Scale up cervical cancer elimination with secondary prevention strategy | Eric Fleutelot, Expertise France, France |
| 13:40 – 13:50 | Scaling up HPV testing and portable thermal ablation devices in Kenya | Lance Osiro, CHAI, Kenya |
| 13:50 – 14:00 | Anal cancer programme for gay men and other men who have sex with men in Nigeria | Rebecca Nowak, University of Maryland Baltimore, United States |
| 14:00 – 14:10 | Towards an anal cancer screening algorithm | Mary Poynten, Kirby Institute UNSW, Australia |
| 14:10 – 14:30 | General discussion | |
| 14:30 – 15:00 | Break (coffee, tea and afternoon snack provided) | |
| 15:00 – 15:45 | Session 4 – Current and future research gaps Chair: Joel Palefsky, University of California San Francisco, United States |
|
| 15:00 – 15:45 | Panel discussion Current and future research gaps related to ending HPV-related cancers especially for people living with or affected by HIV |
Richard Hillman, St Vincent’s Hospital, Australia Sinead Delany-Moretlwe, Wits RHI, South Africa Karen Canfell, The Daffodil Centre, Cancer Council NSW and the University of Sydney, Australia Morkor Newman Owiredu, WHO, Switzerland Andrew Doupe, Unitaid Community Engagement Consultant, Australia |
| 15:45 – 16:00 | Break (no additional catering provided) | |
| 16:00 – 17:00 | Session 5 – Call to action Chair: Adeeba Kamarulzaman, Monash University, Malaysia |
|
| 16:00 – 16:10 | Keynote Global Fund perspectives on the financing and integration of HPV-related cancer prevention and treatment with HIV services |
Roslyn Morauta, Global Fund, Switzerland |
| 16:10 – 17:00 | Panel discussion
Commitments to ensure ending cervical cancer by 2030 in all countries and all populations. What would it take to commit to ending all HPV-related cancers by 2030 among people living with or affected by HIV? |
Meg Doherty, WHO, Switzerland Cordelia Katureebe, Ministry of Health, Uganda Lucas de Toca, Department of Foreign Affairs and Trade, Australia Roslyn Morauta, Global Fund, Switzerland Jane Costello, Positive Life NSW, Australia Paulus Ripa, Western Highlands Provincial Health Authority, Papua New Guinea |
| 17:00 – 18:00 | Networking reception | |
Sign up to participate
To encourage the broadest participation in the pre-meeting, attendance will be free. However, the meeting will be in person only and limited to 250 attendees. Please note you may only sign up for one IAS 2023 pre-meeting.
Event at capacity and registration is closed. Add your name to the waiting list by emailing pcc@iasociety.org.
Please note that signing up for the pre-meeting does not grant you access to IAS 2023; a separate registration is required for the main event.
See full event description here.
Proudly supported by major donor and organizing partner:
With support from bronze sponsor:
With support from:
